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Abstract
Background: Multigenic diseases are often associated with protein complexes or interactions involved in the same
pathway. We wanted to estimate to what extent this is true given a consolidated protein interaction data set. The
study stresses data integration and data representation issues.
Results: We constructed 497 multigenic disease groups from OMIM and tested for overlaps with interaction and
pathway data. A total of 159 disease groups had significant overlaps with protein interaction data consolidated by
iRefIndex. A further 68 disease overlaps were found only in the KEGG pathway database. No single database
contained all significant overlaps thus stressing the importance of data integration. We also found that disease
groups overlapped with all three interaction data types: n-ary, spoke-represented complexes and binary data – thus
stressing the importance of considering each of these data types separately.
Conclusions: Almost half of our multigenic disease groups could potentially be explained by protein complexes
and pathways. However, the fact that no database or data type was able to cover all disease groups suggests that
no single database has systematically covered all disease groups for potential related complex and pathway data.
This survey provides a basis for further curation efforts to confirm and search for overlaps between diseases and
interaction data. The accompanying R script can be used to reproduce the work and track progress in this area as
databases change. Disease group overlaps can be further explored using the iRefscape plugin for Cytoscape.
Background
Disease definition and classification is an open problem
and, nowadays, the traditional phenotype-based defini-
tions and classifications such as the International Classi-
fication of Diseases (ICD-10) [1] or the Systematized
Nomenclature of Medicine (SNOMED) [2] have been
enriched with molecular-based classifications with roots
in genetic association databases such as Online Mendelian
Inheritance In Man (OMIM) [3] and Genetic Association
Database (GADB) [4], biological network analyses [5-7]
and over-representation engines such as the DICS (dense
modules from protein interaction networks) repository [8]
and DAVID [9,10].
As a sample of these works, Goh et al. [6] introduced
the term “Diseasome” while generating a bipartite graph
of all known genetic disorders (disease phenome) to the
list of known disease genes (disease genome). They pre-
sented a “Disease Gene Network” (DGN) connecting
genes related to the same diseases, and a “Human Dis-
ease Network” (HDN), connecting diseases related to
the same gene. Lage et al. [7] introduced a network link-
ing protein interactions to human disease groups gener-
ated by text mining techniques, in an attempt to re-
define disease according to annotation in databases, and
developed a predictor of genes to be considered as
related to some diseases. Feldman et al. [5] generated
their own disease-interactome network and examined
the network properties of disease-related gene muta-
tions, finding that genes with intermediate connectivity
are more probably disease-related and that disease genes
display significant functional clustering. Dietmann et al.
[8] generated a web-based repository of protein com-
plexes and computationally predicted functional mod-
ules, which allows the user to detect complexes or
modules significantly enriched in a list of genes.
Most of the previous works start from protein inter-
action networks (PINs) constructed by merging a few
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popular databases without explicitly stating how redun-
dant information is normalized (interaction records from
different databases may support identical or similar pro-
tein interactions but using different identifiers or data
models). In addition, some of these studies use mathem-
atically generated “modules” that do not necessarily cor-
respond to a biological concept or observation. These
factors make it difficult to cross-compare strategies for
examining relationships between diseases and inter-
action data.
In this paper, we present an analysis of the overlaps be-
tween disease groups and interaction data as well as path-
way data. The work represents a baseline analysis that can
be easily reproduced using the provided data sets and
scripts. We use the iRefIndex as a source of interaction
data consolidated from 13 different databases [11] where
proteins are normalized to a canonical representative in
order to limit redundancy (for example, by representing
all splice-isoforms of a protein using a single representa-
tive) [12,13]. This redundancy issue is especially important
given that we employ the hypergeometric test in order to
assess overlap between disease groups and interaction
data. In addition, we pay special attention to treating sep-
arately overlaps between disease groups and the three
types of interaction data: from binary records, n-ary
records and spoke-represented complex records [14]. We
show that each is an important source of complementary
data. Finally, we show how disease-interaction overlaps
can be monitored from one release of iRefIndex to an-
other as the underlying data sets grow. In this paper, we
have restricted our analysis to a simple ad-hoc definition
of disease groups – titles from OMIM records are grouped
using regular expressions to identify highly-similar titles
describing various sub-types of the same disease. The
causative genes are assembled into a “disease group”. This
is a conservative grouping method and is easily repro-
duced – the groups themselves are also provided in the
additional material. Other, more sophisticated disease and
phenotype groupings are possible and the provided groups
of disease genes can be easily replaced for comparison
purposes.
We focus on the relationship between disease groups
and protein groups, such as complexes or pathways, to
assess to what extent groups of genes that are phenotyp-
ically related are involved in the same protein group.
Many known diseases are multigenic in nature and, in
some cases, may encode different partners in the same
interaction, complex or pathway; disruption of any of
these may lead to a related phenotype [15,16]. One ex-
ample is the disease known as “Cerebral Cavernous Mal-
formations” (CCM). According to OMIM, there are
three types of CCM: CCM1 has been related to the
KRIT1 gene, CCM2 to the CCM2 (Malcavernin) gene
and CCM3 to the PDCD10 gene. A search in iRefIndex
reveals that these three genes belong to a single complex
(IntAct ID = EBI-1573226). Therefore, a “CCM” disease
group may be confidently related to one malfunctioning
protein complex. In addition, some diseases have been
reported to be related to dimers (for example, Retinitis
pigmentosa and Nephrotic syndrome), ligand-receptor
disruption (Hirschprung disease and Alagille syndrome)
or pathway disruption (Congenital disorder of glycosyla-
tion) [17]. A more complicated example is “Fanconi
Anemia”. The 13 genes causing Fanconi Anemia have
been recently grouped into three categories [18]: 8 genes
form the so-called “Fanconi Anemia core complex”, 2
genes belong to the “FA-ID complex”, 3 other genes act
downstream as regulators, and all three groups have
been called the “FA pathway”.
These cases represent known relationships between
diseases and complexes (or pathways) and they are often
cited in the literature as evidence supporting the idea
that similar phenotypes may have underlying molecular
associations. We wished to examine this idea for a
spectrum of diseases in order to determine how broadly
applicable it may be. In a previous paper, we introduced
a plugin for Cytoscape (iRefScape [19]) that allows the
user to search for interaction data related to any one of
the disease groups used in this paper. Here, we examine
how likely a user is to retrieve statistically significant
results that may help shed light on the mechanism of a
disease. We also lay the ground work to track the pro-
gress of this result set over time as disease-group and
interaction data evolve.
Results
We compared thirteen protein interaction databases (con-
solidated in iRefIndex) to groups of proteins that are
assumed to be involved in related diseases, which we
called “Disease Groups” (DiG), in order to computation-
ally determine all known diseases that might be related to
known protein complexes and interactions in humans.
After that, we performed a similar analysis for pathway
databases. All analyses, tables and figures can be repro-
duced using the accompanying R script (Additional file 1).
Construction of disease groups
Human inherited phenotypes and their related genes
found in the OMIM Morbid Map [20] were assembled
into related groups based on their titles, as described in
Methods. This method provided groups of genes that
were used throughout the remainder of the study to
identify related complexes and subnetworks found in
protein interaction databases.
Each table-entry from the OMIM Morbid Map
describes a potential causal relationship between some
gene listed in Entrez Gene [21] and a disease listed in
OMIM. We used a system of regular expressions to
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identify sets of OMIM disease titles that were either
identical or similar in order to arrive at groups of genes
that were associated with phenotypically related diseases.
Each group of related genes was assigned a distinct Dis-
ease Group Identifier (DiG ID) using this method.
The OMIM Morbid Map contained 5504 entries. 4116
of these entries contained strong evidence (evidence
code 3) for a relationship between a gene and a disease.
These were assigned to 1585 distinct disease groups
(DiG IDs) where each group contained between 1 and
59 genes. Only 497 disease groups contained two or
more associated genes and Additional file 2 shows the
distribution of genes for these multigenic disease groups
is highly skewed (mean 5.33 genes per DiG, standard de-
viation 6.57, skewness 4.22, median 3, mode 2 genes per
group). 94.4% of the multigenic DiGs (469) have be-
tween 2 and 14 genes per DiG. The most complex disor-
ders, in terms of number of associated genes, are:
Deafness (59), Mental retardation (52), Leukemia (45),
Diabetes mellitus (44), Retinitis pigmentosa (43), Colo-
rectal cancer (38) and Cardiomyopathy (37).
A total of 2437 human genes are involved in all disease
groups and 1940 in multigenic groups (2 or more genes).
The complete table of disease groups, their correspond-
ing Entrez GeneIDs and OMIM identifiers are provided
in Additional file 3. A summary table including gene and
protein information per DiG is provided as Additional
file 4. In this table, the DiG Name corresponds to the
string identified by our regular expressions and, in most
cases, can be used as a valid name for a disorder whose
variants can be interpreted as specific disease subtypes
corresponding to the distinct OMIM entries in the
group; however, in a few cases, this string is only part of
what should be a descriptive name of the inherited dis-
order, such as “viral infection”, which stands for “suscep-
tibility to viral infection”, or “molybdenum cofactor”,
which stands for “molybdenum cofactor deficiency”.
Of course, some genes or even sets of genes are
involved in multiple disease phenotypes; for example
BRCA1 (Entrez GeneID: 672) is implicated in forms of
both breast cancer and Fanconi Anemia. As such, our
disease groups can be thought of as nodes in a graph
where two disease groups share an edge if they share
one or more genes. We examined these overlaps be-
tween disease groups and found that 398 of the disease
groups share at least one gene with one other group 837
times and that 130 of these are significant (hypergeo-
metric test, p < 0.01, false-discovery rate (FDR) adjusted).
The resulting DiG network is a sparse graph composed
mostly of isolated DiGs and a few larger components
that contain DiGs related to such diseases as cancer and
eye-disorders (Figure 1). These DiGs and their overlaps
may be further explored using Cytoscape and Additional
file 5. We show below that some protein complexes
overlap with multiple disease groups when those disease
groups are themselves closely related.
In a few cases, our disease grouping method failed to
group together multiple OMIM entries and their asso-
ciated genes because their titles are completely different.
For example, Digenic iminoglycinuria (DiG 689) and
Hyperglycinuria (DiG 631) both contain the same three
genes. This complete overlap between two disease
groups happens in only one other case. We found that
OMIM entries describing phenotypically related diseases
are named uniformly for the most part and decided that
this regular expression method provided easily interpret-
able groupings sufficient for an initial survey of inter-
action data. These groups are provided as a baseline
method but could be easily replaced with alternatives in
future studies.
Overlap between disease groups and n-ary data
The human network may be divided into two data types.
Edges between protein nodes represent evidence for
some relationship (direct or indirect, physical or genetic)
between just those two proteins. We refer to these data
as “binary” interaction records. In contrast, original
source records from databases may list three or more
protein interactors. In these cases, the experimental evi-
dence is incapable of supporting a binary relationship
between any given pair of proteins in the list; instead,
the evidence simply supports the idea that all of the pro-
teins are somehow related via some unknown set of dir-
ect or indirect binary interactions. The iRefIndex
network contains a second node type to represent a
complex of proteins. Edges between a complex node and
a protein node represent membership of the protein in
that complex. We refer to this data type as n-ary or
“complex” data. A more detailed explanation of inter-
action data types used in this paper and their representa-
tion is included in the methods section along with a
Figure at the end of this paper.
Source databases including this type of information for
Homo sapiens include IntAct [22], HPRD [23], CORUM
[24], DIP [25], BIND [26], MINT [27] and InnateDB
[28], and, to this date, there are a total of 5677 distinct
human complexes.
We assessed the overlap between each of our disease
groups and each complex in the n-ary subset using a
hypergeometric test and adjusting the p-values for mul-
tiple testing using the Bonferroni, FDR and BY methods
(see Methods). From these three metrics, we chose FDR
to identify the best match to the DiG, since it was the
less conservative correction. Results for all DiGs are pro-
vided as Additional file 6.
This table shows that 94 DiGs were found to be sig-
nificantly similar (p-value < 0.05, FDR adjusted) to at
least one complex in the n-ary subset. That is, 19% of
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multigenic DiGs could potentially be explained as com-
plexes where different malfunctioning subunits may give
raise to different varieties of the disease.
DiGs can overlap with multiple n-ary records and we
wanted to have a rough idea of the maximal number of
n-ary complexes that an analyst might have to review
when looking for overlaps with a disease group. DiGs
can match at least one subunit of a number between 0
and 405 complexes (what we have named the “complex
span” of a DiG). However, the significant matches (raw
p-value < 0.05) are between 1 and 350, and the corrected
matches (after the FDR adjustment) have a complex
span between 1 and 40. The most complex disease in
terms of overlapping complexes of the n-ary subset is
colorectal cancer (complex span = 405 and significant
matches = 40), followed by breast cancer (complex span
= 270 and significant matches = 32). In these two cases,
the number of records that would have to be reviewed is
prohibitive. However, these are exceptions and 95% of
all DiGs with significant overlaps match only 8 or fewer
n-ary complexes.
Figure 2 shows one such example. Alport syndrome is
associated with three genes: COL4A5 with the X-linked
form (MIM 301050) while COL4A3 and COL4A4 are
associated with the autosomal-recessive form (MIM
203780). These forms were grouped into disease group
80 based on their similar OMIM titles. Searching for this
disease group in iRefScape for interactions between any
of the proteins in this disease group returns one record
from IntAct describing a complex containing all three
proteins (EBI-2461456). Alport syndrome is in fact a
genetically heterogeneous disorder where all forms result
from mutations encoding type IV collagen components
which form a major structural component of the
Figure 1 Disease groups and their significant overlaps. Cytoscape is used to visualize the disease groups and their overlaps. Additional file 5
can be directly loaded into Cytoscape to replicate the figure and explore the disease groups. Each node represents a group of related diseases
associated with two to 59 genes. Edges represent one or more genes that are shared between disease groups where the width of the edge is
proportional to the Jaccard index. The graph is sparse. Only 837 edges exist between the 497 multigenic disease groups and 130 of these
overlaps are significant (hypergeometric test, p-value < 0.01 after FDR adjustment) – the above shows only these significant overlaps but all are
available in the provided file. A number of connected components group together related disease groups such as cancer and eye disorders (red
box magnified in inset).
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basement membrane. These relationships are noted in
OMIM, however, there are no cross-references to inter-
action data nor is there a complete listing of all six type IV
collagen isoforms (A1-A6) that are components of the type
IV collagen superstructure. This structure is indeed impli-
cated in Alport syndrome (as well as Benign familia
hematuria) but the structure itself is quite complex
(reviewed in [29]). Each of the type IV collagen isoforms
can combine with other isoforms to form trimers: (A1/A1/
A2) or (A3/A4/A5) or (A5/A5/A6). In turn, these hetero-
trimeric protomers can interact with one other protomer
at their amino termini and three other protomers at their
carboxy termini to form the supramolecular-mesh that is
the structural component of type IV collagen. Alport muta-
tions disrupt the formation of the A3/A4/A5 protomer
network thus explaining the molecular etiology of the dis-
ease. The IntAct record (EBI-2461456) corresponds to a
description of this protomer. The record contains no link
back to the OMIM record although links between the dis-
ease and type IVcollagen in general could be indirectly
made by examination of the underlying UniProt records.
While we found that 19% of our disease groups had a
significant overlap with n-ary data, we feel that a manual
review of existing overlaps and a search for new overlaps
would be pre-requisite to reaching any quantitative con-
clusions about the relationship between multigenic dis-
eases and protein complexes - a review of all significant
disease-complex overlaps found in this study showed that
no single database has systematically covered all diseases
for potential overlaps with protein complexes (see below).
So a manual review and search is required and this is non-
trivial. For example, the work involved in confirming just
the one overlap between Alport syndrome and the A3/
A4/A5 protomer required a re-searching of the primary
literature – the interaction record did not cite any experi-
mental evidence and the listed PubMed identifier points
to a publication for the IntAct database itself. This ex-
ample is not isolated nor is the problem specific to any
one database. The record in question pre-dates IMEx cur-
ation rules [30] and would not be accepted today as an
official IMex record. However, these historical records and
those produced by non-IMex member databases are an
important source of disease-complex overlaps. A review of
these data could help put in place curated, reciprocal links
between disease and interaction databases and would fa-
cilitate future automated data mining efforts.
To facilitate this review process, we have included
Additional file 7 that can be used to view all disease-
Figure 2 Alport syndrome and subunits of type 4 collagen. Alport syndrome is associated with three genes: COL4A5 with the X-linked form
(MIM 301050) while COL4A3 and COL4A4 are associated with the autosomal-recessive form (MIM 203780). These forms were grouped into
disease group 80. Searching for this disease group in iRefScape for interactions between any of the proteins in this disease group returns one
record from IntAct (EBI-2461456) describing a complex (hexagon) containing all three proteins (ovals).
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complex overlaps in Cytoscape (Figure 3). A disease
group may overlap with multiple observations of related
n-ary complexes. For example, the region inside the red
box shows an overlap between the Cornelia de Lange
syndrome disease group and multiple n-ary records that
contain subunits of the cohesion complex – all three
causative genes in this disease group are members of the
cohesion complex (MIM 122470). Conversely, a complex
may overlap with multiple disease groups indicating a
potential relationship between the diseases. For example,
(in the green box) Benign familial hematuria (MIM
141200) and Alport syndrome (MIM 203780) are both
renal diseases due to type IV collagen defects of the
basement membrane. Both of these disease groups over-
lap with the collagen protomer described above and
shown in Figure 2.
Overlap between disease groups and regenerated n-ary data
In a previous work [14], we have shown that some pri-
mary databases represent complexes using a spoke
model, making them virtually indistinguishable from
binary data and, therefore, the iRefIndex contains infor-
mation regarding complexes that would normally be
treated as binary data. We developed an algorithm to ex-
tract this information as a set of “regenerated com-
plexes”. This method is currently used by both iRefR
and iRefScape to identify potential spoke-represented
complexes [14,19]. Using “iRefR” with the software de-
fault values, 9947 potential spoke-represented complexes
were regenerated (see Methods).
We assessed the overlap between each of our disease
groups and each complex in the regenerated subset again
using a hypergeometric test and adjusting the p-values for
Figure 3 Disease group overlaps with complexes. Cytoscape is used to visualize disease groups and their overlaps with n-ary interaction
records. Additional file 7 can be directly loaded into Cytoscape to replicate the figure and explore the overlaps. Disease groups (circular nodes)
and n-ary records (hexagonal nodes) that have significant overlaps are indicated by edges whose width is proportional to the jacaard index [31]
for the overlap. All disease-group overlaps with complexes are provided in the additional file. Here, significant overlaps (hypergeometric test,
p-value < 0.0025 after FDR adjustment) are shown on the right and involve 105 disease groups. The region inside the red box shows an overlap
between the Cornelia de Lange syndrome disease group and n-ary records that contain subunits of the cohesion complex. The region inside the
green box (and magnified in the left inset) shows two disease groups (Benign familial hematuria and Alport syndrome) that both overlap with
the same n-ary record (see text for details).
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multiple testing using the Bonferroni, FDR and BY meth-
ods. Results for all DiGs are provided as Additional file 8.
This table shows that 110 DiGs were found to be signifi-
cantly similar to at least one complex in the regenerated
subset. That is, there is potentially more disease related in-
formation in spoke-represented complexes than there is in
complex data represented as such. However, it is important
to note that these “spoke-represented complexes” are only
potential and it is possible that they may simply represent
a set of unrelated binary interactions that, by chance, are
observed in the same study using the same method and
the same bait. A re-reading of the original source paper is
required to distinguish between these two cases.
We reviewed papers for those diseases that had significant
overlaps with the regenerated complexes (but not with n-ary
or binary data). In most cases, our regenerated complexes
were created from these papers because they all described a
set of binary observations that all used the same method
and the same bait protein. It was rare to find descriptions of
bona fide complexes. Figure 4 illustrates one such exception
– two subunits of a sodium channel complex held in com-
mon with the Liddle syndrome disease group.
Therefore, we concluded that while this method
remains a formal possibility for finding overlaps between
diseases and complexes in interaction data, it is not a re-
liable way of identifying complexes but a way to identify
proteins that are usually related functionally. The major-
ity of disease groups detected in overlaps using this
method also had statistically significant overlaps with n-
ary data and/or binary data (see below), therefore, the
method is not critical for retrieving disease group over-
laps (at least in this study).
The complex span (number of regenerated-complexes
that match at least one subunit of a DiG) is a number
between 0 and 1198 complexes. The significant matches
(raw p-value < 0.05) are values between 1 and 1116, and
the FDR-adjusted matches between 1 and 345. However,
95% of all DiGs with significant overlaps match only 11
or fewer regenerated complexes.
Overlap between disease groups and binary data
Binary data is different to the complex data that we have
analyzed so far, therefore we have reformulated our ques-
tion as how probable it is to find a statistically significant
Figure 4 Liddle syndrome. Mutations in either SCNNB or SCNNG are associated with Liddle syndrome (disease group 772). Both are subunits of
the heterotrimeric (alpha, beta, gamma) nonvoltage-gated, amiloride-sensitive, sodium channel. Both proteins were observed together with
SCNN1A (the alpha subunit of the channel) as interactors with syntaxin 1A (STX1A). The original paper [32] contains evidence for a direct
interaction between STX1A and the gamma subunit and for a complex that includes all four proteins using in-vitro translated components
(Figure one in [32]). The complex is represented as four binary interactions in the BioGrid database. These interactions are identified as part of a
potential spoke-represented complex by iRefScape (a grey hexagon appears after selecting View Tools/Show spoke-represented complexes from
the iRefScape menu).
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number of binary interactions between the proteins
belonging to a DiG. That is, in a network of 16272 pro-
teins, there are 132,380,856 possible interactions but only
113,733 are documented. In order to find out how prob-
able it is to find a certain number of interactions among
the proteins belonging to a DiG, given this background,
we performed a new hypergeometric test which uses a sig-
nificant p-value of 0.0004 as a correction for the fact that
the probability of randomly finding an interaction is
dependent on the degree, as explained in Methods. Results
for all DiGs are provided as Additional file 9.
This table shows that 87 DiGs were found to be signifi-
cantly enriched in binary interactions. Groups of proteins
found to have association or over-representation can po-
tentially have a biological meaning. Therefore, this result
may reflect that there is a way of grouping proteins,
related to the disease, for which we do not currently have
a full explanation, although we can also hypothesize that
they may correspond to unknown complexes, pathways,
or other forms of functional organization. Again, a review
of the literature underlying the interactions in each case is
required before coming to a conclusion. These results
simply provide a ranked list of those disease groups that
are associated with an unexpectedly high number of bin-
ary interactions. The iRefScape plugin for Cytoscape can
be used to explore specific disease groups (either by
searching for the disease group or the associated list of
proteins). Figure 5 shows one example involving Glycine
encephalopathy.
Combined list of disease group overlaps by interaction
data type
Combining the lists of DiG overlaps related to n-ary,
regenerated and binary data, we found a total number of
159 DiGs (out of 497 starting DiGs) that may be related
to complexes or other forms of functional organization.
The main contributors to this result were the regener-
ated n-ary and n-ary data sets followed by the binary
data set.
We expect that our tables of significant matches will
be useful to a more detailed study of the identity, simi-
larity and nature of the matching complexes to a given
DiG. However, this is not practical for DiGs that have
overlaps with a large number of complexes. In these
cases, a visual interface such as iRefScape can facilitate a
review of the data – here similar complexes can more
easily be identified and compared. However, a significant
number of disease groups overlap with a manageable
number of complexes and 66 out of the above 159 dis-
ease groups can be confidently related to one single pro-
tein complex (only one significant p-value after FDR
adjustment).
These data are summarized in Figure 6 using a Venn
diagram with the differences and coincidences between
the DiG-interaction matches after using iRefIndex's n-
ary data, regenerated data and binary data as sources.
The diagram shows that some matches are found using
two or three of the data sources indicating the presence
of mutually supportive data for half of the disease groups
with significant overlaps. A total of 37 DiGs have signifi-
cant overlaps with all three data sets.
However, 24 DiGs only overlap with n-ary complexes,
25 overlap only with regenerated complexes, and 20 are
only enriched for binary data. This suggests that the
three data sources are complementary and should be
used together in order to create a full picture. Tables 1,
2 and 3 are summary tables for the DiG overlaps found
using only n-ary, regenerated or binary data respectively.
Additional file 10 lists all disease groups and their best
overlaps with each of the three data types. The reader
can use these tables as a guide to diseases that have sig-
nificant overlaps with interaction data. R code to retrieve
reference information for each complex and DiG pair is
provided in Additional file 1 (section 12).
Analysis per database and study type
We examined the list of distinct n-ary complexes that
had the best significant overlap with each disease group
in order to investigate the primary databases in iRefIn-
dex from which matching complexes were retrieved.
There are 79 distinct complexes overlapping with 94 dis-
ease groups. Table 4 shows that these are described in
seven different primary databases (IntAct, HPRD,
CORUM, DIP, InnateDB, MINT and BIND), which high-
lights the importance of interaction database integration
as a requisite to explore relationships to diseases. We
note that 61 out of the 79 best matching complexes are
derived from low-throughput studies (as indicated by an
lpr score smaller than 22: see Methods), which indicates
that they preferentially come from low throughput
experiments and that the results are not dependent on
high-throughput studies.
We also examined the list of distinct regenerated com-
plexes that had the best significant overlaps with each
disease group. There were 89 distinct complexes over-
lapping with 105 disease groups. Table 5 shows that the
89 best matching regenerated complexes are derived al-
most entirely from BioGRID [33] while only a few come
from IntAct and MINT. This is expected since BioGRID
represents n-ary data using a spoke model (the intended
target of regenerated complexes).
For binary interactions, 12 out of 13 databases in the
“iRefIndex” provide human binary data (these are all the
above-mentioned databases plus OPHID [34], MPPI [35]
and MatrixDB [36]). OPHID is a source of predicted
interactions in human based on orthologous transfer
from observations in other experimental organisms.
OPHID did not have overlaps with diseases in the n-ary
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(complex) data set since predicted interactions are based
solely on binary interaction records. Given that 94 dis-
ease groups significantly overlapped with the n-ary
records that are present for human, we speculate that
orthologous transfer of n-ary data from other experi-
mental organisms to human could provide a useful
source of information.
Overlap between disease groups and pathways
As a complementary analysis, we decided to evaluate the
overlap between our DiGs and a pathway database. We
selected the KEGG database [37], although the analysis
could be extended to others.
Additional file 11 contains detailed results. In sum-
mary, KEGG pathways match 172 DiGs (p-value < 0.05,
FDR adjusted): 104 matches already detected by inter-
action sources and 68 new matches. Therefore, KEGG
lacked significant overlaps with only 55 disease groups
that had overlaps in the iRefIndex data. Figure 7 shows a
detailed Venn diagram of overlaps between disease
groups and all three interaction data types plus pathway
data.
These results suggest that pathway and interaction
data sources may be complementary although further
examination of individual cases will be required to con-
firm this. This work is non-trivial and we suggest that
the disjoint lists of diseases found by either KEGG or by
interaction databases alone would make a good starting
point for a collaborative curation project to investigate
further the disease coverage of these data sets. In the
meantime, there is good reason to consult both inter-
action and pathway data when performing disease-
related analyses [14].
Change of results over time
In order to see how conclusions change with time, we have
compared all previous analyses between the iRefIndex ver-
sions 8.0 (January 19th, 2011) and 9.0 (October 18th, 2011).
Figure 5 Glycine encephalopathy. Mutations in any one of three genes can cause Glycine encephalopathy (see MIM 605899 and disease group
542). All three potential pairwise interactions are found as predicted interactions in the OPHID database. No other database in iRefIndex includes
these interactions. The three proteins are all part of the glycine decarboxylase complex; a loosely associated multienzyme complex consisting of
four proteins that catalyzes the oxidative cleavage of glycine to carbon dioxide, ammonia, and a methylene group, in a multistep reaction. The
fourth subunit (DLDH_HUMAN a.k.a. DLD or GCSL) has no interactions with any of the above three subunits in the iRefIndex. DLD is also a
subunit of the branched-chain alpha-keto acid dehydrogenase complex (BCKD). Mutations in DLD or any other of the three catalytic subunits of
this complex can lead to Maple Syrup Urine Disease (MIM 248600) – a disease with similar phenotype. This complex is not detected by any of
the methods shown in this study since interactions between its subunits are not present in iRefIndex.
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Table 6 shows that there is an increase in interaction
records, both binary and complex, and disease genes with
interaction information, from one version to the next. The
direct consequence of this is that there is also an increase
in n-ary and regenerated groups, as well as binary-enriched
DiGs, and an increase in matches between DiGs and all
three sources. Moreover, it is important to highlight that
not only the number of DiG-complex matches grows but
also the number of matches detected with only one of the
data sources (at least for n-ary and regenerated data), indi-
cating that using different sources has become more im-
portant with time. Table 6 also shows that more databases
contribute with significant information to the analysis
(InnateDB was not present in iRefIndex 8.0), while the
number of databases with spoke-represented complexes in
need of being regenerated remains the same (BioGRID, In-
tAct, MINT). Finally, 9 of the matches detected using
KEGG but not interaction data from iRefIndex 8.0 were
found using iRefIndex 9.0. The methods and scripts devel-
oped here will provide us with the means to monitor how
these trends progress over time.
Discussion
Our overview of the relationship between diseases and
protein interaction data indicates that roughly half of
our disease groups could potentially be explained in
terms of groups of proteins, which may be complexes,
spoke-represented complexes, groups of binary interac-
tions or pathways. These matches can occur between a
disease group and either one or many protein groups
(complex span). The situation as of release 9.0 of the
iRefIndex is detailed in the different tables and supple-
mentary tables.
In summary, 227 DiGs (out of 497 multigenic DiGs)
show significant similarity to a number of n-ary com-
plexes (94), regenerated complexes (105), binary-groups
(87) or pathways (172) and the number of matches per
DiG ranges between 1 and 345, numbers that seem to
increase as databases grow.
We have shown that disease group overlaps can be
found within three types of interaction data: n-ary,
spoke-represented complexes and binary. These sources
are complementary and should be examined separately
when searching for overlaps. It is particularly interesting
that a large number of distinct overlaps were found with
spoke-represented data: a data set that would not nor-
mally be amenable to overlap detection unless the ana-
lyst specifically attempted to detect binary data that was
potentially describing a protein complex. However, we
found that this data set by itself was unable to reliably
identify bona fide complexes when we examined the
source papers even though it was identifying a function-
ally related group of proteins.
One goal of this work was to assess how important
data integration is to this type of study. Since interaction
databases are so redundant and since there are already
databases that have specialized in capturing human-
specific information and even complex data, one might
conclude that not all data resources are really required.
However, we found that interaction data and pathway
data appear to be complementary and that overlaps with
all three types of interactions included records from sev-
eral databases. Therefore integration of data sources is
an important issue if analysts are to detect all significant
overlaps with a disease. The quality and usefulness of
these overlaps from individual databases is beyond the
scope of this survey. This should be addressed in future.
Here, we have found sufficient evidence to show that no
single database has systematically subsumed all signifi-
cant disease group overlaps and that all diseases have
not been thoroughly covered by the collective set of
databases examined here. We would argue that this
could be addressed by future collaborative efforts be-
tween these databases.
It is important to qualify these results and place them
in the context of future studies. First, our method of cre-
ating disease groups is a fairly conservative and simple
string-matching technique that could be replaced by
more sophisticated methods [7] or disease-phenotype
classifications. Further, examination of these statistically
significant overlaps is required to assess how often these
groups truly represent relevant complexes or pathways
that can offer an explanatory basis for a disease group.
The accompanying tables, scripts and the iRefScape plu-
gin provide the means to direct, facilitate and track
n−ary regenerated
binary 0
20
25
20
24
10
23
37
Figure 6 Diagram of DiG overlaps with each of three different
interaction data types. A Venn Diagram shows that some DiGs
correlate to a complex or complexes found at only one of the three
protein information sources (24 DiGs when using n-ary data, 25 for
regenerated complexes and 20 for binary interactions between the
DiG proteins). At the same time, it can be seen that some DiGs are
significantly similar to complexes found in more than one of the
three protein interaction information sources.
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further study and curation efforts. These could be direc-
ted towards the significant overlaps found here and also
towards the disease groups for which we did not find
overlaps in interaction data or pathway data.
In the meantime, the data presented in this survey and
the disease group search functionality in the iRefScape
plugin can act as a guide towards searching for disease-
relevant interaction data across a number of databases.
Conclusions
This paper has examined the current relationship be-
tween diseases and protein interaction data. However,
these results will change over time and, therefore, we
prefer to place emphasis on the importance of data inte-
gration, the variety of data types that need to be taken
into account and the tools we have developed for these
analyses, which can allow future researchers to access
updated results.
The predictions obtained from our results could be
used as a feedback to interaction, complex and disease
databases. iRefIndex includes no disease annotation, due
to the fact that complex records in interaction databases
rarely contain references to diseases or to OMIM. The
work presented here could be used to systematically re-
view and put in place cross-references between OMIM
and interaction databases.
Methods
All analyses were performed using R 2.14.1 and iRefR v.
0.94. Additional R libraries used in this paper include
Table 1 DiGs related only to complexes found in n-ary data
DiG ID DiG name # Genes Best match
(icrigid)
Complex
span
# significant
p-values (raw)
# significant
p-values (FDR)
6 3-methylcrotonyl-coa carboxylase 2 1209480 9 9 2
65 Albinism 3 1209579 1 1 1
80 alport syndrome 3 781937 4 4 1
89 Amyloidosis 6 1221863 26 22 9
168 bethlem myopathy 3 1027975 5 5 1
192 Bradyopsia 2 969965 1 1 1
259 Ceroid 8 1232651 6 3 1
302 combined cellular and humoral immune defects 2 1220789 1 1 1
313 congenital disorder of glycosylation 23 725907 28 26 4
578 Hematuria 2 781937 4 4 1
595 hereditary hemorrhagic telangiectasia 2 618400 1 1 1
690 immune dysfunction 2 1122614 5 5 2
758 leigh syndrome 14 1211293 44 36 13
812 maple syrup urine disease 4 1225549 12 11 1
870 mitochondrial complex 16 1211293 28 24 5
975 omenn syndrome 3 1220789 1 1 1
998 Osteoporosis 5 869728 5 5 2
1108 Propionicacidemia 2 1209480 5 5 2
1266 stickler syndrome 3 878437 4 4 1
1341 tumoral calcinosis 4 682939 3 3 1
1345 ullrich congenital muscular dystrophy 3 1027975 5 5 1
1477 celiac disease 4 1220318 2 1 1
1512 intervertebral disc disease 2 893696 1 1 1
1520 Leprosy 4 651466 7 7 1
Summary of the 24 DiGs that can be related to protein complexes but can only be found in iRefIndex n-ary data: Mitochondrial complex deficiency (DiG ID = 870)
is a DiG that groups 16 genes. At least one of the 16 genes in this DiG was present in 28 complexes present in iRefIndex n-ary data (complex span = 28) and 24 of
them could be considered as significantly similar after a hypergeometric test with a p-value < 0.05. After adjusting the p-values for multiple testing using the FDR
method, only 5 of those complexes could be considered significantly similar to the DiG, and therefore, their subunits related to the diseases involved in the DiG.
The best match, among those 5, is the complex with the icrigid = 1211293, which corresponds to the complex in the CORUM database with
interaction identifier = 15317750.
“3-methylcrotonyl-coa carboxylase” stands for “3-methylcrotonyl-coa carboxylase 1 deficiency” and “3-methylcrotonyl-coa carboxylase 2 deficiency”, while “Ceroid”
stands for “Ceroid lipofuscinosis” and “Mitochondrial complex” stands for Mitochondrial complex I, II, III and IV deficiencies.
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“limma”, “gplots”, “moments”, “org.Hs.eg.db” and “igraph
(version 0.5.5)”. The “iRefR”, “gplots” and “moments”
packages can be installed from CRAN [38], while
“limma” and “org.Hs.eg.db” can be installed from Bio-
conductor [39]. All code necessary to replicate the R
analyses in this paper (except the construction of
DiGs) is provided as Additional file 1. The Cytoscape
graphs were generated using Cytoscape 2.8.2 and
iRefScape 1.18 using version 9.0 of iRefIndex (see
http://irefindex.uio.no).
Table 2 DiGs related only to regenerated complexes
DiG ID DiG name # Genes Best match (database.pmid.exp_method.icrogid) Complex
span
# significant
p-values (raw)
# significant
p-values (FDR)
63 alagille syndrome 2 MI:0463(grid).pubmed:10958687.MI:0004(affinity
chromatography technology).1144108.MI:0463(grid).
pubmed:10958687.MI:0096(pull down).1144108
4 4 1
190 Brachydactyly 7 MI:0463(grid).pubmed:9525338.MI:0096(pull down).248458 13 12 1
246 central hypoventilation
syndrome
6 MI:0463(grid).pubmed:10829012.MI:0096(pull down).4168707 13 12 1
271 Chondrodysplasia 6 MI:0463(grid).pubmed:9525338.MI:0096(pull down).248458 13 13 1
290 cockayne syndrome 2 MI:0463(grid).pubmed:10944529.MI:0004(affinity
chromatography technology).660979
11 11 2
363 Deafness 59 MI:0463(grid).pubmed:12485990.MI:0096(pull down).1981308 134 56 1
424 endometrial carcinoma 5 MI:0463(grid).pubmed:8942985.MI:0096(pull down).813561.
MI:0463(grid).pubmed:10029069.MI:0096(pull down).813561.
MI:0463(grid).pubmed:9774676.MI:0096(pull down).813561.
MI:0469(intact).pubmed:9774676.MI:0096(pull down).813561
105 103 5
451 Exostoses 2 MI:0463(grid).pubmed:17353931.MI:0004(affinity
chromatography technology).3748087.MI:0469(intact).
pubmed:17353931.MI:0006(anti bait coip).3748087
13 13 1
512 gastric cancer 11 MI:0469(intact).pubmed:19411071.MI:0006(anti bait coip).3231405 194 190 2
687 Ichthyosis 13 MI:0469(intact).pubmed:17373842.MI:0006(anti bait coip).1386965 25 21 1
714 jackson-weiss syndrome 2 MI:0463(grid).pubmed:20388777.MI:0004(affinity chromatography
technology).3027803
16 16 1
730 Keratosis 6 MI:0463(grid).pubmed:11790773.MI:0004(affinity chromatography
technology).2791010
65 60 5
772 liddle syndrome 2 MI:0463(grid).pubmed:14996668.MI:0004(affinity chromatography
technology).382851
14 14 8
829 medullary thyroid
carcinoma
2 MI:0463(grid).pubmed:8183561.MI:0004(affinity chromatography
technology).1871880
26 26 1
904 Mycobacterium 10 MI:0463(grid).pubmed:10848598.MI:0004(affinity chromatography
technology).1004542
45 42 2
933 nephrotic syndrome 4 MI:0463(grid).pubmed:11733557.MI:0004(affinity chromatography
technology).3453124.MI:0463(grid).pubmed:11733557.MI:0096
(pull down).3453124
8 8 1
959 noonan-like/multiple
giant cell lesion syndrome
2 MI:0463(grid).pubmed:9344843.MI:0004(affinity chromatography
technology).5369795
100 100 1
999 Osteosarcoma 2 MI:0463(grid).pubmed:12242661.MI:0004(affinity chromatography
technology).3633225
340 340 318
1049 pfeiffer syndrome 2 MI:0463(grid).pubmed:20388777.MI:0004(affinity chromatography
technology).3027803
16 16 1
1051 pheochromocytoma 6 MI:0463(grid).pubmed:10829012.MI:0096(pull down).4168707 115 109 1
1071 pituitary hormone 5 MI:0463(grid).pubmed:10788441.MI:0096(pull down).3747010 9 9 1
1165 rhabdomyosarcoma 4 MI:0463(grid).pubmed:17662948.MI:0004(affinity
chromatography technology).2068280
30 30 1
1233 Sitosterolemia 2 MI:0471(mint).pubmed:16870176.MI:0007(anti tag coip).3242301 2 2 1
1260 squamous cell carcinoma 3 MI:0463(grid).pubmed:15659383.MI:0401(biochemical).4258047 52 52 12
1574 Tuberculosis 3 MI:0463(grid).pubmed:7673114.MI:0096(pull down).4202157 9 9 1
Summary of the 25 DiGs that are significantly similar to protein complexes but can only be found in iRefIndex regenerated complex data: Ichthyosis (DiG ID = 687)
is a DiG that groups 13 genes. At least one of the 13 genes in this DiG was present in 25 complexes present in iRefIndex regenerated n-ary data (complex span =
25) but only 21 of them could be considered as significantly similar after a hypergeometric test with a p-value < 0.05. After adjusting the p-values for multiple
testing using the FDR method, only 1 of those complexes could be considered significantly similar to the DiG.
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Construction of consolidated protein interaction data set
Protein interaction data was consolidated from 13 differ-
ent databases using the iRefIndex procedure described
previously [11,19]. Each node in the resulting PIN repre-
sents a distinct sequence from a distinct organism. Fur-
ther, groups of related proteins (for example, splice
isoforms) are represented by a single representative from
each group (canonical representation). As a result, each
Entrez GeneID in a disease group will map (at most) to
a single node in this PIN.
The final network (iRefIndex release 9.0 – October,
2011) describes (after consolidation) 401,140 distinct
human protein-protein interactions. A subset of interac-
tions where both interactors were human proteins was
used in this study and contained 361,059 distinct interac-
tions. The corresponding PSI-MITAB file used in this
study is available at ftp://ftp.no.embnet.org/irefindex/data/
current/psimi_tab/MITAB2.6/ or can be downloaded using
iRefR [14] or searched and viewed using iRefScape [19].
An explanation of interaction data types and their
representation
Figure 8 shows a detailed explanation of the different
interaction data types and their representations used in
this paper. This figure describes binary data, n-ary data
and regenerated complexes as well as spoke, matrix and
bipartite models for representing n-ary data.
A. A binary type experiment. The yeast two-hybrid
method is a typical binary type method. Two fusion
proteins are created: a transcription factor DNA-
binding domain fused to a bait protein (a) and a
transcription activation domain fused to a prey
protein (b). An interaction between a and b restores
transcriptional activation (red arrow) of a reporter
gene that can be detected in an in vivo assay
(experiments 1–3).
Table 3 DiGs enriched only in binary interactions
DiG ID DiG name # Genes # binary
interactions
in DiG
p-value
156 basal cell carcinoma 4 2 1.1e-05
263 charcot-marie-tooth disease 26 4 2.0e-4
305 Immunodeficiency 12 4 3.8e-07
310 retinal dystrophy 22 4 5.4e-05
379 diabetes mellitus 44 12 7.7e-11
538 Glutaricaciduria 4 3 1.3e-08
542 glycine encephalopathy 3 3 6.3e-10
543 glycogen storage disease 19 6 1.1e-08
581 Hemochromatosis 5 2 3.3e-05
626 Hypercholesterolemia 9 3 4.4e-06
628 Hyperekplexia 5 2 3.3e-05
644 Hyperphenylalaninemia 4 2 1.1e-05
780 Lissencephaly 5 2 3.3e-05
850 Methemoglobinemia 4 2 1.1e-05
996 Osteopetrosis 8 2 2.7e-4
1081 polycystic kidney 4 2 1.1e-05
1092 Porphyria 6 5 1.4e-12
1153 retinitis pigmentosa 43 8 1.6e-06
1300 Thrombocythemia 3 2 2.2e-06
1536 myocardial infarction 13 4 7.4e-07
Summary of the 20 DiGs that are enriched in iRefIndex binary interactions and
can only be found using this method: Glycine encephalopathy (DiG ID = 542) is
a DiG that groups 3 genes. There are 3 possible interactions between 3 genes.
Finding all of them in the PIN is a very unlikely event (hypergeometric p-value
close to zero) and, therefore, the existence of a functional group of proteins
related to the disease can be hypothesized.
“immunodeficiency” stands for immunodeficiencies due to defects in CD3,
MAPBP-interacting protein, with hyper IgM and X-linked.
Table 5 Sources of significant regenerated data
Database(s) Number of best matches to DiGs
BioGRID 73
IntAct 8
Mint 3
BioGRID & IntAct 3
BioGRID & Mint 1
IntAct & Mint 1
Number of best matches to DiGs per source database. 3 different databases
contribute with regenerated complexes that happen to match at least one
DiG. BioGRID is the main contributor to this group of complexes. The table
shows that the process of regenerating potentially spoke-represented
complexes may be important to detect information on protein groups
matching DiGs.
Table 4 Sources of significant n-ary data
Database(s) Number of best matches to DiGs
IntAct 24
CORUM 16
HPRD 13
DIP 6
InnateDB 5
DIP & IntAct 5
Mint 4
BIND & CORUM 2
DIP, MINT & InnateDB 1
BIND 1
CORUM, IntAct & HPRD 1
CORUM & IntAct 1
Number of best matches to DiGs per source database. 7 different databases
contribute with complexes that match at least one DiG. In 87% of the cases
the complex belongs to only one database. The other 13% can be found in 2
or 3 databases at the same time. The table shows how using only a subset of
databases instead of a consolidated data set may lead to incomplete results
regarding DiG matches.
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B. Results of a binary experiment. The results of
three different experiments (experiments 1–3, each
using bait protein a and one bait protein (b, c or d))
are recorded in three different interaction records
and provide evidence for interactions between a and
b, a and c and a and d. Other types of experiments
can produce binary data. What binary type methods
have in common is that the output of each
experiment produces a record with only two
proteins. Depending on the experiment type, the
results may constitute evidence for a direct
interaction (e.g. yeast 2-hybrid) or an indirect
interaction (e.g. synthetic lethal screen).
C. Graphical representation of a binary experiment.
The results of experiments 1–3 can be represented
using a graph. Proteins a, b, c and d are the nodes
and edges between nodes represent the fact that
experimental evidence exists supporting an
interaction between those two proteins.
D. An n-ary type experiment. An
immunoprecipitation pull-down assay is a typical
n-ary type method. A bait protein (e) is fused to an
epitope and expressed in vivo. Cell lysate is
immunoprecipitated using an antibody specific to
the epitope tag (red) on protein e. Proteins binding
directly (or indirectly) to e are captured as part of
the immunoprecipitate and detected using some
method such as mass spectrometry.
E. Results of an n-ary experiment. The results of the
immunoprecipitation and detection (experiment 4)
are captured in a single interaction record that lists
all of the observed proteins (e, f, g, h) and notes the
protein used as bait (e). Other types of experiments
can produce n-ary data. What n-ary type methods
have in common is that the output of each
experiment can produce a record with three or
more proteins. N-ary results may be represented as
a list of protein interactors using the PSI-MI XML
format (see http://www.psidev.info/node/60).
However, n-ary results cannot be represented in a
single MITAB formatted record because each
record (in MITAB format) can list no more that
two interaction participants (panel M). In order to
represent these data in MITAB format, they must
first be transformed into a binary-like format using
one of three methods: panels (G-K).
F. Graphical representation of an n-ary experiment.
The results of an n-ary type experiment cannot be
rendered as a graph like the one in panel C. The
experimental observations show that the proteins in
the list are somehow associated but contain no
information about interactions between any given
pair of proteins. However, n-ary data is quite
commonly transformed using one of three methods
(panels G, I, K) such that they can be represented
using a graph and combined with binary data like
that shown in panel C.
G. Spoke representation of n-ary data. Interaction
records are created for each protein (f, g, h) that
was observed to be associated with the bait protein
(e). Protein e is called the hub and each of its
interactions with the observed prey proteins is
A
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Figure 7 Diagram of DiG overlaps with three different interaction data types and KEGG data. A Venn diagram of the number of disease
groups that have significant overlaps with each of the three interaction data types and the KEGG pathway database. A. n-ary data. B. regenerated
complex data. C. binary data. D. KEGG data. Diseases lacking significant overlaps with KEGG are evenly spread among the three interaction types.
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called a spoke. In n-ary experimental systems that
do not use a bait protein (e.g. x-ray
crystallography of a multi-subunit complex), one
of the observed proteins will be arbitrarily chosen
to represent the hub in the spoke model. Spokes
do not constitute evidence for an interaction;
they serve to group together proteins in a series
of binary records that were all associated in one
experimental result. Each of these records will
list the same study, the same n-ary method and
the same bait protein (if applicable). Therefore, in
a MITAB record (see panel M below), the fact
that the results of an n-ary experiment are being
represented with a spoke model is implicit – it is
left to the user to notice if an n-ary type method
is being used and that there are other records (in
the same MITAB file) that share a common
experimental reference and bait. With the recent
introduction of MITAB version 2.7, a new
column (called expansion), explicitly states if the
record is part of a spoke model. See http://code.
google.com/p/psicquic/wiki/MITAB27Format.
H. Graphical representation of spoke data. The data
from panel E can be represented in a graphical
format. Note that the topology of graphs in panels
C and H are identical even though the meaning is
completely different; the presence or absence of an
edge between protein nodes does not constitute
evidence for or against an interaction.
I. Matrix representation of n-ary data. Interaction
records are generated for all possible pairwise
combinations of proteins observed in experiment 4.
This representation is less common than the spoke
model. Like the spoke model, this representation
serves to group together members of a list of
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a b y2h intact 123456 bait
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a d y2h intact 123456 bait
e f ip biogrid 7890123 bait
e g ip biogrid 7890123 bait
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Figure 8 An explanation of interaction data types and their
representation. Experiments that can be used to detect
interactions may produce binary data (panels A-C) or n-ary data
(panels D-F). N-ary data is commonly represented using one of
three different models: the spoke model (panels G-H), the matrix
model (panels I-J) or the bipartite model (panels K-L). Some n-ary
data is represented using a spoke model and an attempt can be
made to detect these records in MITAB files and reconstruct the list
of component proteins in a potential complex (panel M). These lists
are referred to as regenerated complexes in this paper. The full
explanation of this Figure is provided in the Methods section.
Table 6 Comparison of results using iRefIndex version 8.0
and iRefIndex 9.0
Variable iRefIndex
8.0
iRefIndex
9.0
# Human-Human Interaction records 319447 361059
# Genes in Morbid Map with PI info in iRefIndex 1685 1719
# Genes in Morbid Map without PI info in iRefIndex 256 222
# DiGs with non-translatable genes 166 156
# n-ary groups 4827 5677
# regenerated groups 7830 9947
# binary nodes in PIN 15597 16272
# binary edges in PIN 98853 113733
# significant matches DiG-nary 81 94
# significant matches DiG-regenerated 96 105
# binary-enriched DiGs 84 87
# all significant DiGs 220 227
# DiG matching only nary data 16 24
# DiG matching only regenerated data 22 25
# DiG matching only binary data 21 20
# databases with nary data matching DiGs 6 7
# databases with regenerated data matching DiGs 3 3
# nary groups with lpr < 22 (low-throughput) 53 61
# Matches found using KEGG and not found using
iRefIndex
77 68
The first 8 rows show how knowledge about the human interactome grows
from one database release to the next; that is, the growth of the number of
interaction records (319447 to 361059), the number of genes associated to
disease in OMIM having interaction information in iRefIndex (1685 to 1719),
the number of complexes coming from n-ary (4827 to 5677) and regenerated
(7830 to 9947) data, and the number of binary nodes and edges in the PIN.
This leads to an increase in the number of matches between DiGs and each of
the three data sources (nary, regenerated, binary) and, in total, an increase
from 220 to 227 matching DiGs from one release to the following one. The
number of DiGs matching only one type of data also grows, as well as the
number of databases with n-ary data matching DiGs.
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proteins that are experimentally observed to be
associated.
J. Graphical representation of matrix data. The data
from panel I can be represented in a graphical
format. The same caveats apply as in panel H
(except that there will be no missing edges).
K. Bi-partite representation of n-ary data. An
artificial node is created (C) to represent the idea of
a complex. Interaction records are made for each
protein observed in experiment 4 and this complex
node. This representation is the least common. It is
used by iRefIndex to represent n-ary data in its
MITAB file distribution – such records cannot be
mistaken for binary records because they each list
only one protein. Source database records that are
of the form shown in panel E (a list of proteins) will
be represented in the iRefindex MITAB using this
model. However, source database records that were
distributed as a spoke model (as in panel G) will not
be represented this way by iRefIndex. In these cases,
we must use a heuristic algorithm to try to detect
those sets of binary records that are likely to be
spoke representations of n-ary data – an n-ary
record can be inferred from this search (see panel
M). In this paper, we call these inferred n-ary
records regenerated complexes.
L. Graphical representation of bi-partite data. The
representation shown in panel K can be rendered in
a graphical format. A circular node represents a
protein. A hexagonal node represents a complex
node. An edge between a protein and a complex
node represents membership of the protein in that
complex. The graph uses two node types and is
therefore referred to as a bi-partite graph.
M.MITAB format. A MITAB file is a tab-delimited text
file where each row represents one interaction
record. This panel shows selected fields of a MITAB
file for experimental results in panel B (results of a
binary experiment) and panel G (spoke
representation of results from an n-ary experiment).
The first three rows constitute evidence for
interactions between a and b, a and c and a and d.
The last three rows are potentially spoke
representations of a single immunoprecipitation
experiment where e was observed to be associated
with proteins f, g, and h. We can infer that this set
of records supports the idea of a complex between e,
f, g and h because 1) they all share a method that is
known to potentially generate n-ary
(immunoprecipitation), 2) they all come from the
same source database (BioGrid), 3) they all refer to
the same publication and they all involve the same
bait protein (experimental role of A is bait in all
three cases). In this paper we therefore create a
regenerated complex composed of the list of
proteins e,f,g,h. This list is amenable to the
hypergeometric test. However, it is also possible that
these three records are all descriptions of
experimental results from three separate
experiments in the same paper – in which case
there is no evidence of an association that involves
these four proteins at the same time. In most cases,
it is impossible to distinguish between these two
cases by just looking at the XML or MITAB version
of the interaction record and a re-reading of the
paper is necessary to confirm the legitimacy of the
regenerated complex.
Construction of disease groups
The OMIM Morbid Map (June 14th, 2010) was obtained
from the OMIM FTP site [20]. Each entry in this table
describes a relationship between some OMIM disease
entry and some gene from Entrez Gene. Each entry con-
tains 4 pipe-delimited columns that list (1) the disease
title, OMIM identifier referring to the disease and an
evidence code, (2) the official gene symbol and its syno-
nyms for the gene that is related to this disease, (3) the
OMIM identifier referring to this disease-gene relation-
ship and (4) locus information for the associated gene.
We restricted our analysis to those entries with evidence
code 3 meaning that evidence for an association between
the disease phenotype and the gene was obtained by
mapping both a mutation associated with the disease to
the wild-type gene and by mapping the disease pheno-
type itself to the gene [40]. The Morbid Map was pre-
processed to assign integer Entrez GeneIDs to each
Morbid Map entry. Gene symbols from column 2 were
used to search for the corresponding Symbol in Entrez-
Gene’s gene_info table and restricting search results to
taxon identifier 9606 (human) and ensuring that the cor-
responding map location information matched what was
given in the Morbid Map entry. In those cases where no
hit was found, the search was broadened to include
matches to Synonyms and LocusTag entries in the gen-
e_info table.
Groups of disease-gene associations were constructed
using disease titles (first column in the Morbid Map). In
some cases, multiple entries have identical titles; these
were assigned to the same Disease Group Identifier
(DiG ID). However, titles were not always exactly the
same and varied in the detail given. These variations
often describe disease sub-types or are a result of simple
naming inconsistency. Regular expression rules were
used to group identical or similar Morbid Map entries
under a common DiG ID. To initiate the text search,
titles in column 1 were stripped of everything following
the first comma (in the absence of a comma, the disease
tag and OMIM identifier were removed) or everything
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following keywords “due to” or “with” that tend to spe-
cify subtypes of a main phenotype. Before the search for
matching titles, white spaces, stand-alone digits and
roman numerals were also removed. The resulting
search strings were anchored at the beginning to select
for partial title hits. Two kinds of opening brackets
(“{“,”[“) were allowed to occur at the beginning - these
brackets are used by OMIM as a special symbol to indi-
cate susceptibility to certain conditions. A Structured
Query Langage (SQL) regular expression search was
used to form an initial group of hits. Every partial hit
was examined. To be accepted, the match had to either
end at the word boundary or with punctuation
(“,”,”-”,”/”,”(“) or to continue with allowed suffixes (pres-
ently “s”, “tous”, “tosis” to accommodate matches of, for
example, adenomatous and adenomatosis). Testing for
word boundaries was necessary to exclude false matches
that result from partial word matching. All approved
matches were assigned the same integer DiG ID.
Regenerated complexes
The process of regenerating spoke-represented com-
plexes has been described in our previous work [14]. We
used “iRefR” to regenerate complexes, following a ca-
nonical representation of proteins and the default list of
experimental methods, that is, the methods with the fol-
lowing MI-ontology terms: MI:0004, MI:0006, MI:0007,
MI:0019, MI:0027, MI:0028, MI:0029, MI:0059, MI:0061,
MI:0071, MI:0096, MI:0114, MI:0226, MI:0227, MI:0401,
MI:0437, MI:0676, MI:0858 and MI:0963 (see [41] under
“interaction detection method”). As a result, 9947
human complexes were included in the analysis.
This reconstruction algorithm doesn't guarantee that
we are identifying biologically functional complexes, but
it guarantees that these proteins always co-purify and
were reported in the same paper and database, which
differs from other methods of generation of complexes
from binary data such as clustering methods.
Translating Entrez gene IDs to proteins
Entrez GeneIDs in DiGs were mapped to canonical
group identifiers (icrogid) using “iRefR”, which, in turn,
uses the information from iRefIndex version 9.0. This
method ensures that each gene maps to, at most, one
protein in the iRefIndex data set.
156 DiGs had genes with no corresponding protein
(icrogid). These genes were included in all analyses as
non-mappable entities, meaning that they could not
match any protein in a complex but they are still a
member of the disease group for statistical purposes.
Assessing overlap between disease groups and complexes
Following Goldberg et al. [31], we used four simi-
larity metrics: the Jaccard, Meet/Min, Geometric and
Hypergeometric indexes, and we observed that hyper-
geometric indices gave the best results. We implemented
two types of hypergeometric test:
In the first type, the population corresponds to the
total number of distinct proteins in DiGs plus complexes
(or pathways), the success population corresponds to the
proteins in complexes (or pathways), the sample corre-
sponds to each DiG, and the success sample to the inter-
section between each DiG and complex (or pathway).
In this case, the null hypothesis that the two groups
(DiG and protein group) were independent was rejected if
the corrected p-value was ≤ 0.05, i.e., a p-value smaller
than a cutoff of 0.05 indicated a match. The resulting
p-values were adjusted for multiple hypothesis testing
(each complex or pathway considered as one different
test) using the Bonferroni, False Discovery Rate and
Benjamini-Yekutieli methods, using “p.adjust” in R. Bon-
ferroni was the most conservative correction and FDR the
less conservative, therefore we used the FDR adjusted
p-value every time we spoke of the best match or the
number of significant matches.
The second type of test was developed for binary
interaction data. Here, the population corresponds to all
possible binary interactions between proteins in the bin-
ary graph, the success population corresponds to the ac-
tual number of binary interactions reported, the sample
corresponds to the size of all possible interactions
among the proteins in a DiG, and the success sample to
the actual number of binary interactions between the
proteins of that DiG.
This type of test has the limitation that it considers
the probability of finding an interaction for a node is
equally probable for all nodes; however, the fact is that it
is easier to find an interaction for a node with a high
degree than for a node with a low degree. In order to
correct for this, we performed 10,000 Monte-Carlo
simulations for each disease group, selecting proteins of
similar degree to the members of the real DiG for each
simulation and counting the number of interactions in
the simulated subgraph. The obtained results were
equivalent to those of the uncorrected hypergeometric
test using a cutoff of a p-value < 0.0004 and, therefore,
we used the hypergeomtric test with the smaller cutoff
as our final method instead of the more time-consuming
simulations.
Additional files
Additional file 1: This is a plain text file that contains R code to
reproduce all R analyses in the paper. See http://www.r-project.org/.
Additional file 2: Distribution of number of genes per disease
group (DiG).
Additional file 3: Mapping of OMIM titles to disease groups and
Entrez Gene identifiers.
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Additional file 4: Summary of disease groups in terms of both
genes and proteins.
Additional file 5: The file can be opened in Cytoscape (http://
cytoscape.org) to reproduce Figure 1 and explore disease groups
and their overlaps.
Additional file 6: Overlaps between disease groups and n-ary
records showing best overlaps (icrigid) and number of overlaps
(complex span) before and after correction for multiple hypothesis
testing. Additional information on n-ary records with the best overlap
with a disease group can be found at http://wodaklab.org/iRefWeb/
interaction/show/xxx where xxx is the icrigid ( for example,
http://wodaklab.org/iRefWeb/interaction/show/705064).
Additional file 7: The file can be opened in Cytoscape
(http://cytoscape.org) to reproduce Figure 3 and explore disease
groups and their overlaps with n-ary data in iRefIndex.
Additional file 8: Overlaps between disease groups and
regenerated complex data showing best overlaps and number of
overlaps (complex span) before and after correction for multiple
hypothesis testing. Example regenerated complexes have regular
names that can be used to retrieve the binary interactions that make up
the regenerated complex. For example: in the name “MI:0463(grid).
pubmed:10722728.MI:0004 (affinity chromatography
technology).10724593”, the BioGrid database has curated interactions
from the paper with PubMed Identifier 10722728 where an affinity
chromatography method was used to identify interactors of a common
bait (icrogid: 10724593).
Additional file 9: Significance of overlaps between disease groups
and binary data was calculated as described in the text. Number of
interaction edges for each disease group is listed. Only those disease
group overlaps with raw p-values less than 0.0004 are considered
statistically significant.
Additional file 10: Each disease group is listed along with its
number of genes, Entrez Gene IDs, and best overlaps with n-ary
data and regenerated data and most significant raw p-value for
binary data enrichment. Additional information on best overlapping n-
ary record or regenerated complex can be found using the provided
identifier as described in AF6 and AF8. Binary data corresponding to a
disease group can be found using the iRefScape plugin for Cytoscape
using the provided DiG ID or list of Gene IDs.
Additional file 11: Each disease group is listed along with the
number of significant overlaps with KEGG pathway records before
and after correction for multiple hypothesis testing. The KEGG entry
identifier for the best overlapping pathway record is provided in column
3. For example 5200 is record hsa05200.
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